ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of End Points in Noninsulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Hypertension
◽
10.1161/hypertensionaha.111.186064
◽
2012
◽
Vol 59
(1)
◽
Cited By ~ 1
Author(s):
Neeraj Dhaun
◽
David J. Webb
Keyword(s):
Diabetes Mellitus
◽
Uric Acid
◽
Angiotensin Ii
◽
Dependent Diabetes Mellitus
◽
End Points
◽
Post Hoc Analysis
◽
Renal Outcomes
◽
Angiotensin Ii Antagonist
◽
Post Hoc
◽
Losartan Treatment
Download Full-text
Related Documents
Cited By
References
Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Diabetologia
◽
10.1007/s00125-011-2215-4
◽
2011
◽
Vol 54
(8)
◽
pp. 2209-2209
Author(s):
Y. Miao
◽
D. Dobre
◽
H. J. Lambers Heerspink
◽
B. M. Brenner
◽
M. E. Cooper
◽
...
Keyword(s):
Angiotensin Ii
◽
Serum Potassium
◽
Post Hoc Analysis
◽
Renal Outcomes
◽
Angiotensin Ii Antagonist
◽
Post Hoc
Download Full-text
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Diabetologia
◽
10.1007/s00125-010-1922-6
◽
2010
◽
Vol 54
(1)
◽
pp. 44-50
◽
Cited By ~ 56
Author(s):
Y. Miao
◽
D. Dobre
◽
H. J. Lambers Heerspink
◽
B. M. Brenner
◽
M. E. Cooper
◽
...
Keyword(s):
Angiotensin Ii
◽
Serum Potassium
◽
Post Hoc Analysis
◽
Renal Outcomes
◽
Angiotensin Ii Antagonist
◽
Post Hoc
Download Full-text
Faculty Opinions recommendation of Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.725503819.793507757
◽
2015
◽
Author(s):
Luis Ruilope
◽
Enrique Morales
Keyword(s):
Diabetic Nephropathy
◽
Angiotensin Ii
◽
Kidney Disease
◽
Serum Bicarbonate
◽
Post Hoc Analysis
◽
Angiotensin Ii Antagonist
◽
Insulin Dependent
◽
Kidney Disease Progression
◽
Post Hoc
◽
Irbesartan Diabetic Nephropathy Trial
Download Full-text
B029 The effects of angiotensin II antagonist losartan on urinary albumin excretion in non insulin-dependent diabetes mellitus
American Journal of Hypertension
◽
10.1016/s0895-7061(97)90872-4
◽
1998
◽
Vol 11
(4)
◽
pp. 47A
◽
Cited By ~ 1
Author(s):
P RAGONESI
Keyword(s):
Diabetes Mellitus
◽
Angiotensin Ii
◽
Urinary Albumin Excretion
◽
Insulin Dependent Diabetes Mellitus
◽
Urinary Albumin
◽
Insulin Dependent Diabetes
◽
Dependent Diabetes Mellitus
◽
Albumin Excretion
◽
Angiotensin Ii Antagonist
◽
Insulin Dependent
Download Full-text
Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial
Journal of the American Society of Nephrology
◽
10.1681/asn.2006050445
◽
2007
◽
Vol 18
(5)
◽
pp. 1540-1546
◽
Cited By ~ 206
Author(s):
Wouter B.A. Eijkelkamp
◽
Zhongxin Zhang
◽
Giuseppe Remuzzi
◽
Hans-Henrik Parving
◽
Mark E. Cooper
◽
...
Keyword(s):
Blood Pressure
◽
Diabetic Nephropathy
◽
Angiotensin Ii
◽
Post Hoc Analysis
◽
Angiotensin Ii Antagonist
◽
Post Hoc
◽
Type 2 Diabetic
Download Full-text
Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
American Journal of Kidney Diseases
◽
10.1053/j.ajkd.2013.09.016
◽
2014
◽
Vol 63
(2)
◽
pp. 244-250
◽
Cited By ~ 41
Author(s):
Hiddo J. Lambers Heerspink
◽
Misghina Weldegiorgis
◽
Lesley A. Inker
◽
Ron Gansevoort
◽
Hans-Henrik Parving
◽
...
Keyword(s):
Diabetic Nephropathy
◽
Angiotensin Ii
◽
Kidney Failure
◽
Estimated Gfr
◽
Post Hoc Analysis
◽
Angiotensin Ii Antagonist
◽
Insulin Dependent
◽
Gfr Decline
◽
Post Hoc
◽
Irbesartan Diabetic Nephropathy Trial
Download Full-text
Faculty Opinions recommendation of Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1092298.546712
◽
2007
◽
Author(s):
Luis Ruilope
Keyword(s):
Blood Pressure
◽
Diabetic Nephropathy
◽
Angiotensin Ii
◽
Post Hoc Analysis
◽
Angiotensin Ii Antagonist
◽
Post Hoc
◽
Type 2 Diabetic
Download Full-text
Faculty of 1000 evaluation for Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT).
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718171154.793487536
◽
2013
◽
Author(s):
Enyu Imai
Keyword(s):
Diabetic Nephropathy
◽
Angiotensin Ii
◽
Kidney Failure
◽
Estimated Gfr
◽
Post Hoc Analysis
◽
Angiotensin Ii Antagonist
◽
Insulin Dependent
◽
Gfr Decline
◽
Post Hoc
◽
Irbesartan Diabetic Nephropathy Trial
Download Full-text
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)
American Journal of Kidney Diseases
◽
10.1053/j.ajkd.2015.03.032
◽
2015
◽
Vol 66
(3)
◽
pp. 450-458
◽
Cited By ~ 20
Author(s):
Elise Schutte
◽
Hiddo J. Lambers Heerspink
◽
Helen L. Lutgers
◽
Stephan J.L. Bakker
◽
Priya Vart
◽
...
Keyword(s):
Diabetic Nephropathy
◽
Angiotensin Ii
◽
Kidney Disease
◽
Serum Bicarbonate
◽
Post Hoc Analysis
◽
Angiotensin Ii Antagonist
◽
Insulin Dependent
◽
Kidney Disease Progression
◽
Post Hoc
◽
Irbesartan Diabetic Nephropathy Trial
Download Full-text
Abstract #295 GLP-1 Receptor Agonists and Death From Any Cause in Elderly Patients with Type 2 Diabetes Mellitus: A Post-Hoc Analysis
Endocrine Practice
◽
10.1016/s1530-891x(20)47140-x
◽
2018
◽
Vol 24
◽
pp. 80-81
Author(s):
Konstantinos Toulis
◽
Krishna Gokhale
◽
G. Neil Thomas
◽
Wasim Hanif
◽
Krishnarajah Nirantharakumar
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Elderly Patients
◽
Post Hoc Analysis
◽
Receptor Agonists
◽
Post Hoc
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close